scorecardresearch
Add as a preferred source on Google
Saturday, September 27, 2025
TopicVaccine

Topic: Vaccine

Flagging bird flu’s ‘pandemic potential’, ICMR calls on private firms to collaborate on human vaccine

India's apex health research body has warned that H5N1 infection in humans has a high case fatality rate, exceeding 50 percent.

India’s Vaccine Regulation System Meets WHO Standards

A review was carried out by international experts between 16 and 20 September.

ICMR back in race to offer world’s 1st vaccine for deadly shigella, to tie up with Indian manufacturer

ICMR had in 2019 licensed technology for scaling up and commercialisation of its shigella vaccine to MSD-Wellcome Trust Hilleman Laboratories, but the deal fell through.

BRICS Vaccine Research Center launched in India

New Delhi: In a statement issued after the meeting, Union Health Secretary Apurva Chandra said that the BRICS Vaccine Research and Development Centre, established...

Government signs MoU with UNDP for capacity building and digitalization of vaccine cold chain management

This partnership aims to enhance the digitalization of vaccine cold chain management, capacity building, and communication planning in India.

Panel will keep watch for violation of new drug marketing code, says pharma secretary

Implemented in March, UCPMP 2024 will look into complaints regarding unethical practices in sector. Code gains significance given that Patanjali is facing SC heat for misleading ads.

Global panel calls for scaling up cholera vaccine supply to combat ongoing upsurge in cases

International Coordinating Group (ICG) on Vaccine Provision (ICG) noted that 473,000 cases of cholera were reported to the WHO in 2022.

Govt for the first time considers pre-exposure anti-rabies shots for kids as dog bite cases ‘rise’

National Centre for Disease Control formed panel to discuss such vaccinations through Universal Immunization Programme. Evidence being gathered to present to NTAGI, it is learnt.

World’s 1st vaccine against chikungunya primed for launch in India, says French drugmaker Valneva

VLA1553, commercially known as Ixchiq, has received USFDA clearance and will be launched in India — which has seen high number of chikungunya cases — after ‘regulatory talks with DCGI’.

WHO recommends 2nd malaria vaccine — why Oxford-SII shot is likely to cost less, have wider reach

The R21 or Matrix-M vaccine has been developed by scientists at Oxford University & is the 2nd to receive WHO recommendation, after RTS,S or AS01 (brand name Mosquirix), approved in 2021.

On Camera

Aamir Khan and Salman Khan are still dodging and deflecting the age question, 20 yrs later

On the first episode of Two Much With Kajol and Twinkle, Aamir Khan and Salman Khan were confronted with another hypocrisy: age gaps. And they didn't come out looking good.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

With MiG-21’s exit, India’s squadron strength hits 6-decade low. What are IAF’s plans for the Tejas

While the IAF remains committed to the Tejas programme and has placed orders for 180 Tejas Mk1A, the force is eagerly waiting for the Tejas Mk 2 version.

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.